Methods: A randomized controlled trial (single blinded) was carried out from August 2017 till
December 2017 on 69 patients who fulfilled inclusion criteria. They were assigned to Group …

Comparison of oral itraconazole and intramuscular meglumine antimoniate in the treatment of
cutaneous leishmaniasis. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Objective is an endemic disease. This study was done to compare the efficacy of
intralesional meglumine antimoniate (MA) with combination of 50% trichloroacetic acid …

Objective: To compare the efficacy and safety of meglumine antimoniate and miltefosine in
the treatment of cutaneous leishmaniasis in Pakistan. Study Design: Randomised-controlled …

Objective To compare the efficacy and safety of meglumine antimoniate 20 mg/kg/day with
combination of meglumine antimoniate 10 mg/kg/day and allopurinol 20 mg/kg/day …

Objective To evaluate therapeutic and adverse effects of meglumine antimoniate (MA)
during systemic treatment of Syrian cutaneous leishmaniasis (CL) patients. Methods In this …

Objective To evaluate the efficacy of combined therapy of meglumine antimoniate and co-
trimoxazole in cutaneous leishmaniasis (CL). Methods 180 patients with active lesions of …

Objective: To compare the efficacy of oral zinc sulfate (ZnSO4) with intramuscular
meglumine antimoniate (MA) in the treatment of cutaneous leishmaniasis. Study Design …

Background and aim: This comparative prospective study was conducted at the Department
of Dermatology, Pak Emirates Military Hospital, Rawalpindi, from August 1, 2018, to January …

Background There is a high prevalence of cutaneous leishmaniosis (CL) in southern Khyber
Pakhtunkhwa and most patients present late. Conventional treatment takes longer and …